Skip to main content

Arnold & Porter Advises Pfizer in Acquisition of Clinical-Stage Biotech Therachon

May 10, 2019

Arnold & Porter advised Pfizer Inc. (Pfizer) on its acquisition of Therachon Holding AG (Therachon), a privately held clinical-stage biotechnology company focused on rare diseases.

The Arnold & Porter corporate team included partners Lowell Dashefsky and Rory Greiss; counsel Marci Settle; and associate Bianca Prikazsky.

» Read the full Pfizer press release.